Protein / target
Erythroid transcription factor
Protein at a glance
Biological role
Sequence-specific double-stranded DNA binding
Research activity
Emerging research
Derived from structured UniProt, Open Targets and literature data on this page.
Protein profile
Canonical identity and biological annotation from UniProt.
Function overview
Transcriptional activator or repressor which serves as a general switch factor for erythroid development.
View complete UniProt function annotationHide complete annotation
Transcriptional activator or repressor which serves as a general switch factor for erythroid development (PubMed:35030251). It binds to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and of other genes expressed in erythroid cells. Activates the transcription of genes involved in erythroid differentiation of K562 erythroleukemia cells, including HBB, HBG1/2, ALAS2 and HMBS (PubMed:24245781)
Subcellular location
Domains and Gene Ontology detail (48)Hide
Gene Ontology
- Cchromatin
- Cnucleoplasm
- Cnucleus
- Cprotein-DNA complex
- Ctranscription regulator complex
- Ctranscription repressor complex
- FC2H2 zinc finger domain binding
- Fchromatin DNA binding
- FDNA binding
- FDNA-binding transcription activator activity, RNA polymerase II-specific
- FDNA-binding transcription factor activity
- FDNA-binding transcription factor activity, RNA polymerase II-specific
Biological roles
What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.
View supporting evidenceHide supporting evidence
Transcriptional regulation
- ·Transcriptional activator or repressor which serves as a general switch factor for eryth…
- ·transcription regulator complex
- ·transcription repressor complex
- ·DNA-binding transcription activator activity, RNA polymerase II-specific
Haemostasis
- ·platelet aggregation
- ·platelet formation
Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.
Translational evidence
Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.
Tractability
Protein degraders — Emerging
View underlying tractability evidence (1)Hide
Raw Open Targets tractability assessment buckets, by modality.
Safety-related annotations
Terms indexed against this target in Open Targets' safety data, with their datasource. These are annotations, not causal claims: the direction of effect (whether activation or inhibition is implicated), species and evidence strength are not captured here, so an entry does not mean that modulating this target is known to cause that condition.
Research activity
Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.
Most cited
Recent
Europe PMC papers linked directly to this protein.